Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer

Clinical trial NCT02489448 · COMPLETED

Trial details

NCT number: NCT02489448
Sponsor: Yale University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2015-11-01
Primary completion: 2021-06-15
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.